Gilead Sciences, Inc. (GILD)
143.13
-1.50
(-1.04%)
USD |
NASDAQ |
Oct 06, 10:41
Gilead Sciences Total Return Level : 211.97 for Oct. 5, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 05, 2026 | 211.97 |
| October 02, 2026 | 212.13 |
| October 01, 2026 | 216.18 |
| September 30, 2026 | 218.45 |
| September 29, 2026 | 221.72 |
| September 28, 2026 | 223.08 |
| September 25, 2026 | 221.20 |
| September 24, 2026 | 219.39 |
| September 23, 2026 | 221.85 |
| September 22, 2026 | 223.75 |
| September 21, 2026 | 220.66 |
| September 18, 2026 | 220.00 |
| September 17, 2026 | 221.14 |
| September 16, 2026 | 216.44 |
| September 15, 2026 | 214.42 |
| September 14, 2026 | 213.38 |
| September 11, 2026 | 209.46 |
| September 10, 2026 | 211.05 |
| September 09, 2026 | 212.27 |
| September 08, 2026 | 213.72 |
| September 04, 2026 | 220.06 |
| September 03, 2026 | 220.39 |
| September 02, 2026 | 218.05 |
| September 01, 2026 | 218.50 |
| August 31, 2026 | 213.28 |
| Date | Value |
|---|---|
| August 28, 2026 | 212.32 |
| August 27, 2026 | 216.95 |
| August 26, 2026 | 215.83 |
| August 25, 2026 | 216.82 |
| August 24, 2026 | 213.86 |
| August 21, 2026 | 212.96 |
| August 20, 2026 | 209.05 |
| August 19, 2026 | 215.12 |
| August 18, 2026 | 209.05 |
| August 17, 2026 | 202.47 |
| August 14, 2026 | 201.65 |
| August 13, 2026 | 201.33 |
| August 12, 2026 | 198.02 |
| August 11, 2026 | 197.88 |
| August 10, 2026 | 193.93 |
| August 07, 2026 | 194.14 |
| August 06, 2026 | 190.72 |
| August 05, 2026 | 192.03 |
| August 04, 2026 | 197.12 |
| August 03, 2026 | 191.14 |
| July 31, 2026 | 189.77 |
| July 30, 2026 | 191.33 |
| July 29, 2026 | 193.44 |
| July 28, 2026 | 195.76 |
| July 27, 2026 | 190.22 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AbbVie, Inc. | 457.77 |
| Regeneron Pharmaceuticals, Inc. | 733.21 |
| Vertex Pharmaceuticals, Inc. | 503.50 |
| Amgen, Inc. | 603.43 |
| Biogen, Inc. | 223.59 |